Celgene Corporation
- industry:
- Pharmaceutical manufacturer
- Nationality:
- American
1986-began as a spin off from Celanese; 1998 - Thaliomid approved by the FDA for use in cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL).
1986-began as a spin off from Celanese; 1998 - Thaliomid approved by the FDA for use in cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL).
